Searched for
MK HAMIED
Cipla shares in focus on Rs 2,000 crore likely block dealCipla's shares are likely to attract attention on Monday as the company's promoters may sell up to a 1.72% stake through block deals. The o...- Cipla promoters to sell 1.72% stake in likely block deal worth Rs 2,000 crore: ReportCipla promoters are likely to sell up to 1.72% stake via a block deal at Rs 1,442 per share, a 6% discount to the current price. This follo...
- Stocks in news: General Insurance Corp, ONGC, SpiceJet, GSK Pharma, CiplaStocks in news: Domestic markets remained steady with minor changes, continuing a gradual uptrend. Key stocks in focus include General Insu...
- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Cipla's MK Hamied resigns from the company due to health reasonsCipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...
- Cipla promoters sell 2.53% stake for Rs 2,751 crore"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...
- Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...
- Samina Hamied to step down as Cipla executive vice chairpersonDrug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...
- Cipla founding family’s stake sale in jeopardy over $13 billion valuation targetProspective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the WestCipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...
- Cipla tanks 5% as promoters sell stake in block dealDr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...
- Sell Cipla, target price Rs 420: Kunal BothraKunal Bothra recommended to keep stop loss at Rs 454.
- Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
- Cipla registers 43.8% fall in Q1 net profit; global CEO Subhanu Saxena resignsConsolidated sales stood at Rs 3,500 crore, compared with Rs 3,760 crore in the year-ago quarter. ET Now poll had estimated sales of Rs 8,3...
- Cipla names Samina Vaziralli as Executive Vice-ChairmanVaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...
- Cipla inducts Samina Vaziralli, chairman YK Hamied's niece to company's boardSamina Vaziralli, niece of Cipla Chairman YK Hamied, was appointed to the company's board on Thursday, thus inducting the next generation.
- Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leadersEven as Hamied prepares genext leaders for Cipla, it’s humanitarian face is out to shake up industry by delivering affordable biosimilar dr...
- Cipla board approves retirement of MK HamiedDrug firm Cipla today approved the retirement of its Executive Vice-Chairman, M K Hamied with effect from March 31, 2014.
- Don't look now, Cipla just might be changing, says Cipla chairman & MD Dr Yusuf HamiedET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.
Load More
